Fortune Business Insights offers a detailed overview of the global market in a report, titled “Wearable Medical Devices Market” Size, Share and Industry Analysis by Product (Diagnostic & Patient Monitoring, Therapeutic), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets) and, Regional Forecast 2019-2026.” As per the report, the market was valued at USD 24571.8 Million in 2018 and is anticipated to reach USD 139353.6 Million by 2026. The report offers a comprehensive overview of the market drivers, trends, opportunities, and other aspects of the market.

To Gain More Insights into the Market, Click Here: https://www.fortunebusinessinsights.com/industry-reports/wearable-medical-devices-market-101070

List Top Companies Covered in Wearable Medical Devices Market are

• Ypsomed AG
• Sonova
• Hologic Inc.
• Siemens Healthcare GmbH
• AiQ Smart Clothing
• NeuroMetrix, Inc.
• Apple Inc.
• SAMSUNG
• Fitbits
• SugarBeat

The global wearable medical devices market is anticipated to exhibit an exponential CAGR of 24.7% through the forecast years. The healthcare industry is revolutionizing owing to the rising adoption of connected devices. As digital technology is gaining immense popularity, wearable medical devices are evolving rapidly in the healthcare sector.

Moreover, the objective of these devices is to not only promote the overall body fitness but to offer active treatment regarding health conditions. From Fitbit to smartwatches, the market is increasingly driven by technological developments with focus on personalized care. Taking about personalized care, technologies such as internet of things (IoT), cloud computing, and others help in retrieving patient data in real-time, thereby allowing physicians to detect the patient’s health condition in advance.

Request a Sample Copy of the Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/wearable-medical-devices-market-101070

In addition to this, it provides valuable information on mergers and acquisitions, product launches, partnerships, and other strategic activities adopted by global players. Several estimations and projections for the leading geographies are also included in the report. All the above information can help our readers to gain valuable insights into the market, thereby helping them to make the right decision before investing in the market.

Rising Importance on Reducing Patient Hospital Stays to Encourage Growth in Asia Pacific Wearable Medical Devices Market

Considering regions, North America is expected to register high growth in the global wearable devices market during the forecast period. In 2018, the market was valued at USD 10146.3 Million. The evolving patient shift towards remote monitoring from traditional is increasing the adoption of wearable devices in this region. The implementation of favourable regulatory policies for the development of smart and advanced wearable devices is another factor driving the market in this region. This, coupled with the rising adoption of advanced healthcare infrastructure, is expected to enable growth in the market.

The market in Europe is expected to create immense growth opportunities owing to the rising aging population. This, along with the rising prevalence of chronic diseases, is accelerating the adoption of wearable devices technologies in this region. Apart from North America and Europe, the market in Asia Pacific is expected to register substantial rate rising improvements in technologies.

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Leading Players operating in the Genomics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

Adoption of Advanced Technologies Renders North America Dominant

From a geographical standpoint, North America dominated the global genomics market in 2018. The region will continue to maintain its dominance through the forecast period. Rapid technological advancements and the presence of sophisticated healthcare infrastructure are driving the market in this region. In 2018, North America was valued at US$ 6,959.3 Mn. The demand for genomic medicine is increasing in North America on account of the rising adoption of personalized medicine and new sequencing technologies.

Europe is expected to display great growth potential owing to the wide availability of funds and the presence of large MNCs. Governments in the U.K. is increasingly making investments in research and development (R&D) activities to favour the expansion of the market in Europe.

The market in Asia Pacific is likely to witness strong growth during the forecast years. The primary factor responsible for the growth is developing healthcare infrastructure. The awareness about genomic technologies is increasing in countries such as India and China, as people in these countries are becoming more aware with regards to the detection of genetic disorders, their treatment and prognosis. All these factors are enabling growth in the market.

Veritas Genetics Launched myGenome to Offer Personalized Services to its Customers

General Electric Company, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., IntegraGen, QIAGEN, BGI, F. Hoffmann-La Roche Ltd, Danaher, and Illumina, Inc. are some of the leading players in the global genomics market. Among these, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Illumina, Inc. are projected to dominate the global market. Strong geographical presence and robust portfolio are factors responsible for their prominent position in the market. Several companies are entering into strategic alliances to better their market position and increase revenue. Bristol Myers Squibb collaborated with Foundation Medicine in March 2017. This collaboration will help the former company to leverage the latter’s molecular information and genomic profiling solutions

The global cosmetic surgery market is likely to gain traction from the ever-increasing number of patients undergoing procedures, such as chin augmentation, breast reduction, and breast augmentation. The American Society for Aesthetic Plastic Surgery (ASAPS) declared that in 2018, breast reduction (18%) and chin augmentation (20%) were two of the most popular surgical procedures in the U.S. This information is given by Fortune Business Insights™ in a recent report, titled, “Cosmetic Surgery Market Size, Share & Industry Analysis, By Type (Surgical Procedures, and Non-Surgical Procedures), By Gender (Males, and Females), By End User (Spas & Cosmetic Surgery Centers, and Hospitals & Specialty Clinics), and Regional Forecast, 2019-2026.” The report further states that the cosmetic surgery market size was USD 50.67 billion in 2018 and is projected to reach USD 66.96 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/cosmetic-surgery-market-102628

Fortune Business Insights™ lists out some of the most reputed companies present in the aesthetic surgery market. They are as follows:

• TETIK
• Westlake Dermatology
• Long Island Plastic Surgical Group, P.C.
• ALLERGAN
• Merz Pharma
• Galderma Laboratories
• Cleveland Clinic
• Other key market players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cosmetic-surgery-market-102628

What Does This Report Contain?

• Elaborate information about the factors that would accelerate the market growth in the coming years.
• Comprehensive data about all those factors that are set to pose as growth barriers.
• In-depth analysis of the cosmetic surgery market trends, challenges, and opportunities.
• A thorough analysis of the competitive landscape and profiles of all the vendors.

Drivers & Restraints-

Rising Emphasis on Reduced Post-surgical Interventions to Propel Growth

The market consists of several prominent companies that are presently focusing on capitalizing their market share by delivering new instruments and products to the masses. Besides, the demand for unique products with reduced post-surgical interventions and adverse effects is aiding these companies in investing huge sums in research and development activities.

Furthermore, patients and healthcare providers are nowadays looking for state-of-the-art products. Coupled with this, the rising emphasis on removing the harmful effects of implants and other similar cosmetic procedures would contribute to the aesthetic surgery market growth in the near future. However, the emergence of non-licensed facilities worldwide may hamper the market growth.

Competitive Landscape-

Key Players Aim to Launch New Products to Upsurge Sales

The market is highly fragmented with the presence of numerous organizations that are striving persistently to gain the maximum share. They are doing so by conducting research and development activities to unveil products with cutting-edge technologies. Below is one of the latest key industry developments:

• April 2018: Merz Pharma GmbH & Co. KGaA, a privately-held pharmaceutical company, based in Germany, launched its new product named Belotero® Lips to treat perioral lines and enhance lips.

TOC Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary
3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1. Statistics: Key Procedures, By Key Countries, 2018

4.2. Pricing Analysis, Key Procedures, By Key Countries, 2018

4.3. Technology Advances, Cosmetic Procedures

4.4. Recent Developments, Key Mergers/ Acquisitions, New Product Launches, etc.

 The global telerehabilitation market size is poised to rise remarkably in the coming years attributable to the technological advancements in the field of healthcare services in collaboration with information, technology, and communications. Telerehabilitation is a medical service for people preferring to stay at home and avail treatment and services. As per a recent report by Fortune Business Insights, titled, “Telerehabilitation Market Size, Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027,” the market value stood at USD 3.32 billion in 2019 and is expected to rise at a CAGR of 13.4% to reach USD 9.13 billion by 2027. The forecast period is set between 2020 to 2027.

Please visit: https://www.fortunebusinessinsights.com/telerehabilitation-market-103112

As per Fortune Business Insights™, some of the significant players in this market include:

• MIRA Rehab Limited (UK)
• (United States)
• Doctor On Demand, Inc. (United States)
• Care Innovations, LLC. (United States)

• American Well (United States)
• NeoRehab
• Hinge Health, Inc. (United States)
• Koninklijke Philips N.V. (Netherlands)
• Other players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/telerehabilitation-market-103112

Drivers & Restraints-

Increasing Geriatric Population Vulnerable to Various Diseases will Promote Growth

Telerehabilitation can address a wide variety of medical services through the means of telecommunication and technology. This is especially helpful in the case of patients residing in remote locations with mobility issues and for the aged population. The increasing geriatric population is a key factor promoting the telerehabilitation market growth. Additionally, a rise in the patient pool for chronic diseases is also set to aid in the expansion of the market in the coming years.

Regional Analysis-

North America Earned Dominance Owing to Presence of Advanced Healthcare Technologies

North America earned the highest telerehabilitation market share on account of the rising adoption of telehealth services, presence of advanced medical services, and increasing inclination towards virtual consultation. This, coupled with the increasing number of geriatric population, their vulnerability to various diseases, and a rise in the number of e-visits are likely to help this region continue dominating the market in the coming years.

On the other side, the market in Asia Pacific is expected to show prominent growth in the coming years attributable to the presence of high rural population, increasing awareness among them, and improving healthcare services in the developing nations.

The global home infusion therapy market size is likely to USD 86.89 billion by the end of 2027 owing to the increasing adoption of home medical services worldwide. In a home infusion therapy setting, a patient receives all medical assistance at home including drugs and biologics via a subcutaneous or an intravenous administrative route. According to a recent report by Fortune Business Insights titled, “Home Infusion Therapy Market Size, Share & Industry Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027,” the value of this market was USD 27.25 billion in 2019 and is expected to grow at a CAGR of 2.2% between 2020 and 2027.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/home-infusion-therapy-market-102989

Fortune Business Insights™ lists out the names of market manufacturers. They are as follows:

• Optum, Inc.
• Infusystem
• Option Care Health Inc.
• Moog Inc.
• CareCentrix, Inc.
• Braun Melsungen AG
• Lincare Holdings Inc.
• Baxter
• Promptcare
• BriovaRx Infusion Services
• Other players

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/home-infusion-therapy-market-102989

The Report Answers the Following Queries

• What is the nature of the market and how fierce is its competition?
• What are the key industry insights to the market?
• What strategies are adopted by players to gain momentum in the market?
• How is the COVID19 pandemic helping the market to grow?

Drivers & Restraints-

Lockdowns Amid COVID-19 Pandemic to Bode Well for the Market

The increasing prevalence of the geriatric population and their vulnerability towards chronic diseases such as cancer, diabetes, and cardiac issues among others stands as major home infusion therapy market devices. In addition to this, the increasing cases of hospital-acquired infections are also propelling people to opt for medical services at home. This, coupled with cost-efficient home treatment faster recovery at home than hospital are likely to bode well for the market.

The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries. Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586

Fortune Business Insights™ presents a list of all the companies operating in the orthopedic medical devices market. They are as follows:

• Smith & Nephew
• Stryker
• Zimmer Biomet
• Medical Devices Business Services, Inc. (Johnson & Johnson)
• NuVasive, Inc.
• Medtronic
• Integra LifeSciences
• Wright Medical Group N.V.
• Össur Corporate
• Globus Medical
• Other prominent players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orthopedic-devices-market-102586

This Report Answers the Following Questions:

• What are the orthopedic medical devices market trends?
• How many opportunities and challenges would the market come across in the near future?
• What are the growth drivers and barriers that the market is likely to face?
• How many segments are present in the market?
• Which companies would generate the highest share during the forecast period?
• Which region is set to remain dominant?

Drivers & Restraints-

Rising Prevalence of Musculoskeletal Diseases to Drive Growth

The American Academy of Orthopedic Surgeons, a provider of educational programs for allied health professionals and orthopaedic surgeons, published a report that affirms that every year in the Unites States alone, approximately 6.8 million patients suffering from several orthopedic injuries come to medical attention. It proves that the rising prevalence of orthopedic injuries and musculoskeletal diseases is further resulting in agonizing physical pain and limited mobility. It is expected to propel the orthopedic devices market growth during the forthcoming years. However, the surgical procedure is very expensive in nature. It may hamper the growth of the market.

The global temperature monitoring system market size is projected to reach USD 3.00 billion by 2027, exhibiting a CAGR of 11.2% during the forecast period. Surging number of COVID-19 cases worldwide will spike the adoption of temperature monitoring devices, shares Fortune Business Insights™ in its report, titled “Temperature Monitoring System Market Size, Share & COVID-19 Impact Analysis, By Product (Analog Temperature Monitoring Devices & Digital Temperature Monitoring Devices), By Type (Contact & Non-Contact) By End User (Healthcare Facilities, Home Care Settings, and Others), and Regional Forecast, 2020-2027”.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/temperature-monitoring-systems-market-102013

List of Companies Profiled in this Market Report:

• Koninklijke Philips N.V. (Netherlands)
• Masimo (S.)
• Omron Healthcare (Japan)
• Geratherm (Germany)
• Braun Healthcare (Germany)
• A&D Company Ltd. (Japan)
• Toshiba Inc. (Japan)
• 3M (U.S.)
• Exergen Corporation (U.S.)
• Other Players

According to the World Health Organization (WHO), as of August 3, 2020, global coronavirus cases stood at 17,918,582, with the reported deaths at 686,703. The COVID-19 infection has been found to spread not only through contact and fomites but recent studies have also shown that it can be transmitted through air. As a result, doctors, physicians, and other healthcare workers are avoiding being in close proximity to patients. This has created a huge demand for remote, sensor-based thermometers that can check and monitor temperatures from a distance, thus preventing spread of the infection among frontline workers. Moreover, security officials at public places are also equipped with these devices to prevent the entry of any infected persons in such spaces.

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: 

https://www.fortunebusinessinsights.com/temperature-monitoring-systems-market-102013

The report states that the global market value stood at USD 1.14 billion in 2019 and shares the following information:

• Exhaustive examination of all the factors driving and restraining the market;
• In-depth analysis of the various market segments;
• Detailed study of the regional developments shaping the market; and
• Tangible research into the competitive landscape of the market.

Market Restraint

Fears of Mercury Poisoning May Inhibit Product Adoption

A major hurdle stalling the temperature monitoring system market growth is the health risks associated with mercury poisoning. Conventional thermometers are filled with mercury because it is the only metal that remains liquid at room temperature and expands at the slightest change in temperature. Thus, mercury-based thermometers can immediately show elevated body temperature. However, despite its effectiveness, breaking of these devices and the resultant mercury spillage is a very real threat that raises understandable concerns among patients. The WHO states that exposure to mercury can have toxic consequences for the digestive, nervous, and immune systems, lungs, eyes, kidneys, and skin. The dangers are even more pronounced in young infants and particularly detrimental for pregnant women. As a result, digital temperature monitoring systems are being widely adopted by health professionals and even by households around the world to prevent exposure to mercury.

Fortune Business Insights offers a detailed overview of the global market in a report, titled “Wearable Medical Devices Market” Size, Share and Industry Analysis by Product (Diagnostic & Patient Monitoring, Therapeutic), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets) and, Regional Forecast 2019-2026.” As per the report, the market was valued at USD 24571.8 Million in 2018 and is anticipated to reach USD 139353.6 Million by 2026. The report offers a comprehensive overview of the market drivers, trends, opportunities, and other aspects of the market.

To Gain More Insights into the Market, Click Here: https://www.fortunebusinessinsights.com/industry-reports/wearable-medical-devices-market-101070

List Top Companies Covered in Wearable Medical Devices Market are

• Ypsomed AG
• Sonova
• Hologic Inc.
• Siemens Healthcare GmbH
• AiQ Smart Clothing
• NeuroMetrix, Inc.
• Apple Inc.
• SAMSUNG
• Fitbits
• SugarBeat

The global wearable medical devices market is anticipated to exhibit an exponential CAGR of 24.7% through the forecast years. The healthcare industry is revolutionizing owing to the rising adoption of connected devices. As digital technology is gaining immense popularity, wearable medical devices are evolving rapidly in the healthcare sector.

Moreover, the objective of these devices is to not only promote the overall body fitness but to offer active treatment regarding health conditions. From Fitbit to smartwatches, the market is increasingly driven by technological developments with focus on personalized care. Taking about personalized care, technologies such as internet of things (IoT), cloud computing, and others help in retrieving patient data in real-time, thereby allowing physicians to detect the patient’s health condition in advance.  

Request a Sample Copy of the Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/wearable-medical-devices-market-101070

In addition to this, it provides valuable information on mergers and acquisitions, product launches, partnerships, and other strategic activities adopted by global players. Several estimations and projections for the leading geographies are also included in the report. All the above information can help our readers to gain valuable insights into the market, thereby helping them to make the right decision before investing in the market.  

Table of Content from Wearable Medical Devices Market:

• Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
• Executive Summary
• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Key Insights
  • Recent Industry Developments- Partnerships, Mergers, and Acquisitions
  • Key Industry Trends
  • New Product Launch by Key Players
  • Technological advancements in Wearable Medical Devices Market
• Global Wearable Medical Devices Market Analysis, Insights and Forecast, 2015-2026
  • Key Findings / Summary
  • Market Analysis, Insights and Forecast – By Product
    • Diagnostic & Patient Monitoring Wearable Medical Devices
      • Activity Monitors/ Trackers
      • Smartwatches
      • Smart-clothing
      • Others (Biosensors, Blood Pressure Monitors, Glucose Monitoring Systems)
    • Therapeutic Wearable Medical Devices
      • Wearable Defibrillators
      • Drug Delivery Devices (Injectors, Patches)

The global pet insurance market size is projected to reach USD 11.25 billion by 2026. The increasing pet adoption in leading countries across the world will have a direct impact on the growth of the market. According to a report published by Fortune Business Insights, titled “Pet Insurance Market Size, Share & Industry Analysis, By Policy Coverage Type (Accident & Illness, Accident Only, Others), By Animal Type (Dog, Cat, Others), By Provider (Public, Private) and Regional Forecast, 2019-2026,” the market was worth USD 6.05 billion in 2018. Driven by flexibility in product offerings, the market will exhibit a CAGR of 8.0% during the forecast period, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/pet-insurance-market-101956

A few of the leading companies that are operating in the global market include:

• Trupanion
• Anicom Holdings
• Nationwide Mutual Insurance Company
• ASPCA
• Healthy Paws Pet Insurance, LLC.
• Embrace Pet Insurance Agency, LLC
• Figo Pet Insurance LLC.
• Agria Pet Insurance Ltd
• 24PetWatch
• Pets Best Insurance Services, LLxC.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pet-insurance-market-101956

The pet insurance market will benefit from the increasing pet adoption in leading countries across the world. Pet insurance refers to a policy that covers medical as well as accidental factors that is associated with the pets. The emphasis on the well-being and health of pets, by private as well as government organizations will create several growth opportunities. The presence of several private organizations offering premium insurance policies will have a positive impact on the growth of the market in the forthcoming years. Several companies are focused on offering novel services as well as concessions in a bid to establishing a stronghold in the market. These factors will aid the growth of the market in the coming years.

The report provides an in-depth analysis of the global pet insurance market. It highlights the latest product launches and recent innovations in the market and states their impact on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years. Forecast values have been provided for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals.

Detailed Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Pricing Analysis of Top Insurers, by Animal Type
   • Pet Adoption Statistics, Across Major Countries
   • Key Merger And Acquisition Strategies by Top Players
   • New Product Launch
5. Global Pet Insurance Market Analysis, Insights and Forecast, 2015-2026
   • Key Findings / Summary
   • Market Analysis, Insights and Forecast – By Policy Coverage Type
     • Accident & Illness
     • Accident Only
     • Others
   • Market Analysis, Insights and Forecast – By Animal Type
     • Cat
     • Dog
     • Others

The global prevalence of primary immunodeficiency is rising, giving impetus to the global “intravenous immunoglobulins market”. A report is published by Fortune Business Insights, titled “INTRAVENOUS IMMUNOGLOBULINS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2018-2025,” offers in-depth insights into the market. As per the report, in 2017 the global market was worth US$ 9,787.6 Mn. The market is anticipated to further expand at a CAGR of 6.2% and reach US$ 15,789.1 by the end of 2025. In terms of indication, the report classifies the global market in primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), and others. Primary immunodeficiency was leading the market in 2017. The segment accounted for 28.6% of the global market in 2017. During the forecast period 2018-2025, the segment is likely to witness expansion at an impressive pace.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Key Players Operating in The Intravenous Immunoglobulins Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• CSL Behring
• Grifols
• A.
• Kedrion S.p.A
• Octapharma
• Bio Products Laboratory Ltd.
• Biotest AG
• China Biologic Products Holdings, Inc.
• LFB SA
• Shanghai RAAS Blood Products Co., Ltd.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intravenous-immunoglobulins-market-100593

North America to Continue Dominating Global Market

The North America intravenous immunoglobulins market was worth US$ 5,587.4 Mn in 2017. The region is further expected to emerge dominant over the forecast period. The increasing number of patients in the region is anticipated to drive the regional market. Moreover, in terms of dominance of route of administration, intravenous (IV) is the most dominating type in developing nations. This is likely to enable growth in market. Besides this, the advanced intravenous immunoglobulins are being rapidly adopted in developed nations. This in response is fueling the demand in market. Asia Pacific is anticipated to expand at a promising CAGR. Owing to the high prevalence of primary immunodeficiency in Asian population, the market is foreseen to witness demand for immunoglobulin.

Grifols, S.A., Leading Market with Better Product Offerings

Analysts at Fortune Business Insights foresees the Grifols, S.A., to emerge as the dominant player in the global market for intravenous immunoglobulin market. This is because this company was leading the market in the year 2017 as well, all because oftheir product offerings and the usual route of administration, whioch ultimately dominated a considerate proportion of share ion the market. Besides this, Grifols, S.A., accounts for largest revenues from well developed regions namely Europe and North America.

Other companies operating in the global iontravenous immunoglobulin market are Bio Products Laboratory Ltd., Kedrion S.p.A, Grifols, S.A., Biotest AG, China Biologic Products Holdings, Inc., Octapharma, and CSL Behring.